These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 318219)

  • 1. Cefoxitin therapy for bacterial endocarditis.
    Webb D; Thadepalli H; Bach V
    Rev Infect Dis; 1979; 1(1):170-4. PubMed ID: 318219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and experimental evaluation of cefoxitin therapy.
    Webb D; Thadepalli H; Bach V; Roy I
    Chemotherapy; 1979; 25(4):233-42. PubMed ID: 378578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fetid foot: lower-extremity infections in patients with diabetes mellitus.
    Fierer J; Daniel D; Davis C
    Rev Infect Dis; 1979; 1(1):210-7. PubMed ID: 318225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
    Perkins RL; Slama TG; Fass RJ; Prior RB; Plouffe JF; Warner JF; File TM
    Rev Infect Dis; 1979; 1(1):165-9. PubMed ID: 318218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cephapirin therapy in infective endocarditis.
    Burch KH; Quinn EL; Saravolatz LD; Madhavan T; Jovanovich JF; Pohlod D
    South Med J; 1983 Apr; 76(4):448-52. PubMed ID: 6836358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients].
    Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K
    Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers.
    Raucher B; Dobkin J; Mandel L; Edberg S; Levi M; Miller M
    Am J Med; 1989 Feb; 86(2):169-72. PubMed ID: 2913783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.
    Jones RN
    Am J Surg; 1988 May; 155(5A):16-23. PubMed ID: 3287964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
    Brook I
    J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical findings of cefoxitin in the treatment of serious infections and the prevention of postoperative infections (author's transl)].
    Ito H; Uno E; Ikeda M; Shimoji T; Higashi S; Yamamoto S
    Jpn J Antibiot; 1981 Sep; 34(9):1307-12. PubMed ID: 7328753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.
    Sweet RL; Robbie MO; Ohm-Smith M; Hadley WK
    Am J Obstet Gynecol; 1983 Feb; 145(3):342-9. PubMed ID: 6218755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications--a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis.
    Kager L; Ljungdahl I; Malmborg AS; Nord CE; Pieper R; Dahlgren P
    Ann Surg; 1981 Mar; 193(3):277-82. PubMed ID: 7011219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN; Barry AL; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoxitin for treatment of infections due to anaerobic bacteria.
    Kirby BD; Busch DF; Citron DM; Finegold SM
    Rev Infect Dis; 1979; 1(1):113-7. PubMed ID: 318212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.
    Ribera E; Gómez-Jimenez J; Cortes E; del Valle O; Planes A; Gonzalez-Alujas T; Almirante B; Ocaña I; Pahissa A
    Ann Intern Med; 1996 Dec; 125(12):969-74. PubMed ID: 8967707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.